Samp JC - Search Results

1

Comparative Effectiveness of Long-Acting Beta₂ -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Samp JC, et al. Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913. Pharmacotherapy. 2017. PMID: 28226405

2

Retracted publications in the drug literature.

Samp JC, Schumock GT, Pickard AS. Samp JC, et al. Pharmacotherapy. 2012 Jul;32(7):586-95. doi: 10.1002/j.1875-9114.2012.01100.x. Epub 2012 May 11. Pharmacotherapy. 2012. PMID: 22581659

3

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β₂-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Samp JC, et al. Ann Pharmacother. 2017 Nov;51(11):945-953. doi: 10.1177/1060028017719716. Epub 2017 Jul 5. Ann Pharmacother. 2017. PMID: 28677404

4

Predicting Acute Exacerbations in Chronic Obstructive Pulmonary Disease.

Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA. Samp JC, et al. J Manag Care Spec Pharm. 2018 Mar;24(3):265-279. doi: 10.18553/jmcp.2018.24.3.265. J Manag Care Spec Pharm. 2018. PMID: 29485951 Free PMC article.

5

Evaluating change using patient-reported outcome measures in knee replacement: the complementary nature of the EQ-5D index and VAS scores.

Lin FJ, Samp J, Munoz A, Wong PS, Pickard AS. Lin FJ, et al. Eur J Health Econ. 2014 Jun;15(5):489-96. doi: 10.1007/s10198-013-0489-9. Epub 2013 Jun 14. Eur J Health Econ. 2014. PMID: 23765331

6

Economic evaluation of the impact of medication errors reported by U.S. clinical pharmacists.

Samp JC, Touchette DR, Marinac JS, Kuo GM; American College of Clinical Pharmacy Practice-Based Research Network Collaborative. Samp JC, et al. Pharmacotherapy. 2014;34(4):350-7. doi: 10.1002/phar.1370. Epub 2013 Nov 11. Pharmacotherapy. 2014. PMID: 24214289

7

Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.

Weil C, Mehta D, Koren G, Pinsky B, Samp JC, Chodick G, Shalev V. Weil C, et al. Among authors: samp jc. J Viral Hepat. 2018 Feb;25(2):144-151. doi: 10.1111/jvh.12800. Epub 2017 Nov 7. J Viral Hepat. 2018. PMID: 28984012

8

Costs and absence of HCV-infected employees by disease stage.

Baran RW, Samp JC, Walker DR, Smeeding JE, Young JW, Kleinman NL, Brook RA. Baran RW, et al. Among authors: samp jc. J Med Econ. 2015;18(9):691-703. doi: 10.3111/13696998.2015.1045423. Epub 2015 Jun 11. J Med Econ. 2015. PMID: 26047262 Free article.

9

Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France.

Samp JC, Perry R, Piercy J, Wood R, Baran RW. Samp JC, et al. Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):307-14. doi: 10.1016/j.clinre.2014.10.013. Epub 2014 Nov 11. Clin Res Hepatol Gastroenterol. 2015. PMID: 25511922

10

Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic review.

Szabo SM, Samp JC, Walker DR, Lane S, Cline SK, Gooch KL, Jimenez-Mendez R, Levy AR. Szabo SM, et al. Among authors: samp jc. Ann Hepatol. 2015 Sep-Oct;14(5):618-30. Ann Hepatol. 2015. PMID: 26256890 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters